New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pioneer in Integrative Medicine Presents New Options For Heavy Metal Chelation At American Chemical Society Meeting and Expo

Modified Citrus Pectin (MCP) Research To Be Discussed at ACS Meeting

SANTA ROSA, CA, August 11, 2004 - Isaac Eliaz, M.D., M.S.C., L.Ac., founder of Better Health Publishing®, will speak about decreasing the total body burden of mercury with a focus on Modified Citrus Pectin (MCP) at the 228th American Chemical Society National Meeting and Exposition on Wednesday, August 25, 2004, in Philadelphia, Pa. Beginning at 9:35 a.m., his 30-minute presentation at the Courtyard Marriot-Ballroom Salon III and IV will address investigations of MCP's prevention and treatment of health problems associated with human exposure to heavy metals and toxins. Dr. Eliaz will also speak on the effects of MCP on cancer.

"The results from our most recent human clinical trial show promise for the therapeutic use of MCP in significantly decreasing the total mercury level, and possibly in the reduction of other heavy metals," says Dr. Eliaz. "With an estimated one in eight women having exceedingly high mercury levels in their bodies, and prostate cancer being the most commonly diagnosed cancer in American men, the possible capabilities and benefits of MCP regarding toxins and cancer are of significant interest to the general public."

MCP is a dietary supplement derived from the peel and pulp of citrus fruit. MCP is mostly known for its effects on inhibiting cancer metastasis, and reducing tumor growth and development, but also has beneficial effects on cholesterol reduction and possibly immune stimulation. Dr. Eliaz was granted two US patents in 2001 and 2002 for new applications of MCP, including using MCP to chelate heavy metals. "Dietary methods that can reduce the toxic load of heavy metals and toxins, without the side effects of intravenous chelation therapies, will provide clinicians with additional options for treatment," states Dr. Eliaz. He and his colleagues have conducted pilot human clinical trials to investigate the use of MCP as a systemic chelator of environmental toxins and in the treatment of prostate cancer.

Better Health Publishing,, a Santa Rosa education-based company, is dedicated to providing responsible information and updates of scientific research on integrative therapies to health care professionals and individuals interested in self-care.

The American Chemical Society,, is a self-governed individual membership organization that consists of more than 159,000 members at all degree levels and in all fields of chemistry. The organization provides a broad range of opportunities for peer interaction and career development, regardless of professional or scientific interests.

The programs and activities conducted by ACS today are the products of a tradition of excellence in meeting member needs that dates from the Society's founding in 1876.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.